AU2003237093A1 - Methods and compositions useful for treating prostate cancer - Google Patents

Methods and compositions useful for treating prostate cancer

Info

Publication number
AU2003237093A1
AU2003237093A1 AU2003237093A AU2003237093A AU2003237093A1 AU 2003237093 A1 AU2003237093 A1 AU 2003237093A1 AU 2003237093 A AU2003237093 A AU 2003237093A AU 2003237093 A AU2003237093 A AU 2003237093A AU 2003237093 A1 AU2003237093 A1 AU 2003237093A1
Authority
AU
Australia
Prior art keywords
methods
prostate cancer
compositions useful
treating prostate
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003237093A
Other versions
AU2003237093A8 (en
Inventor
Richard A. Lerner
Alan Saven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2003237093A8 publication Critical patent/AU2003237093A8/en
Publication of AU2003237093A1 publication Critical patent/AU2003237093A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001193—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; PAP or PSGR
    • A61K39/001194—Prostate specific antigen [PSA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003237093A 2002-04-25 2003-04-21 Methods and compositions useful for treating prostate cancer Abandoned AU2003237093A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37595802P 2002-04-25 2002-04-25
US60/375,958 2002-04-25
PCT/US2003/012392 WO2003090675A2 (en) 2002-04-25 2003-04-21 Methods and compositions useful for treating prostate cancer

Publications (2)

Publication Number Publication Date
AU2003237093A8 AU2003237093A8 (en) 2003-11-10
AU2003237093A1 true AU2003237093A1 (en) 2003-11-10

Family

ID=29270734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003237093A Abandoned AU2003237093A1 (en) 2002-04-25 2003-04-21 Methods and compositions useful for treating prostate cancer

Country Status (2)

Country Link
AU (1) AU2003237093A1 (en)
WO (1) WO2003090675A2 (en)

Also Published As

Publication number Publication date
AU2003237093A8 (en) 2003-11-10
WO2003090675A2 (en) 2003-11-06
WO2003090675A3 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
AU2003293194A1 (en) Compositions and methods for treating prostate cancer
AU2003230750A1 (en) Compositions and methods for treating cancer
EP2671581B8 (en) Compositions and methods for treating cancer
AU2003225535A1 (en) Methods and compositions for treating cancer
AU2003284242A1 (en) Methods and compositions for use in treating cancer
AU2003291356A1 (en) Methods and compositions for treating cancer using proteasome inhibitors
AU2003226301A1 (en) Method of treating cancer
AU2003243373A1 (en) Cell migration inhibiting compositions and methods and compositions for treating cancer
AU2003264068A1 (en) Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents
AU2003302892A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003256847A1 (en) Method of treating cancer
EP1572118A4 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
EP1583536A4 (en) Method of treatment of prostate cancer and composition for treatment thereof
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002341749A1 (en) Methods and compositions for inhibiting the proliferation of prostate cancer cells
EP1626711A4 (en) Compositions and methods for treating cancer
EP1596806A4 (en) Compositions and methods for treating cancer using igsf9 and liv-1
GB0201498D0 (en) Materials and methods for treating cancer
AU2002311859A1 (en) Compositions and methods for treating colorectal polyps and cancer
AU2003219160A1 (en) Methods and compositions for the treatment of cancer
AU2002308642A1 (en) Methods for treating cancer
AU2003238905A1 (en) Surface treating compositions and methods for using same
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2003298708A1 (en) GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
AU2001278068A1 (en) Methods and compositions for predicting prostate cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase